$NVAX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NOVAVAX INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NOVAVAX INC. Get notifications about new insider transactions in NOVAVAX INC for free.
Page: < prev 1 ... 3 4 5 6 7 8 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 16 2010 | NVAX | NOVAVAX INC | DRISCOLL FREDERICK W | VP, CFO & Treasurer | Option Exercise | A | 2.66 | 30,000 | 79,800 | 30,000 | |
Apr 08 2010 | NVAX | NOVAVAX INC | YOUNG JAMES F | Director | Option Exercise | A | 2.38 | 20,000 | 47,600 | 20,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | DRISCOLL FREDERICK W | VP, CFO & Treasurer | Option Exercise | A | 2.35 | 30,000 | 70,500 | 30,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 15,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Option Exercise | A | 2.35 | 60,000 | 141,000 | 60,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 15,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | MARSH JOHN O JR | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 15,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | A | 2.35 | 15,000 | 35,250 | 15,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Option Exercise | A | 2.35 | 150,000 | 352,500 | 150,000 | |
Mar 17 2010 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Option Exercise | A | 2.35 | 100,000 | 235,000 | 100,000 | |
Feb 17 2010 | NVAX | NOVAVAX INC | Erck Stanley C | Director | Option Exercise | A | 2.40 | 300,000 | 720,000 | 300,000 | |
Aug 25 2009 | NVAX | NOVAVAX INC | DRISCOLL FREDERICK W | VP, CFO & Treasurer | Option Exercise | A | 5.21 | 220,000 | 1,146,200 | 220,000 | |
Aug 25 2009 | NVAX | NOVAVAX INC | DRISCOLL FREDERICK W | VP, CFO & Treasurer | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Jul 21 2009 | NVAX | NOVAVAX INC | Trizzino John | Snr. VP, Int & Govt ... | Option Exercise | A | 3.02 | 220,000 | 664,400 | 220,000 | |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.76 | 200 | 552 | 80,000 | 80.2 K to 80 K (-0.25 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.77 | 1,300 | 3,601 | 80,200 | 81.5 K to 80.2 K (-1.60 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.80 | 7,400 | 20,720 | 81,500 | 88.9 K to 81.5 K (-8.32 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.81 | 9,146 | 25,700 | 88,900 | 98 K to 88.9 K (-9.33 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.82 | 3,400 | 9,588 | 98,046 | 101.4 K to 98 K (-3.35 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.83 | 4,500 | 12,735 | 101,446 | 105.9 K to 101.4 K (-4.25 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.84 | 2,900 | 8,236 | 105,946 | 108.8 K to 105.9 K (-2.66 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.85 | 400 | 1,140 | 108,846 | 109.2 K to 108.8 K (-0.37 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Sell | S | 2.86 | 5,500 | 15,730 | 109,246 | 114.7 K to 109.2 K (-4.79 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Option Exercise | M | 0.74 | 150,000 | 111,000 | 0 | |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 3.00 | 50,000 | 150,000 | 113,104 | 163.1 K to 113.1 K (-30.66 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.88 | 2,234 | 6,434 | 163,104 | 165.3 K to 163.1 K (-1.35 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.90 | 22,200 | 64,380 | 165,338 | 187.5 K to 165.3 K (-11.84 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.91 | 7,300 | 21,243 | 187,538 | 194.8 K to 187.5 K (-3.75 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.92 | 15,500 | 45,260 | 194,838 | 210.3 K to 194.8 K (-7.37 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.93 | 5,100 | 14,943 | 210,338 | 215.4 K to 210.3 K (-2.37 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.94 | 4,800 | 14,112 | 215,438 | 220.2 K to 215.4 K (-2.18 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 2.95 | 3,900 | 11,505 | 220,238 | 224.1 K to 220.2 K (-1.74 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 3.00 | 900 | 2,700 | 224,138 | 225 K to 224.1 K (-0.40 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 3.01 | 20,200 | 60,802 | 225,038 | 245.2 K to 225 K (-8.24 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 3.02 | 90,900 | 274,518 | 245,238 | 336.1 K to 245.2 K (-27.04 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Sell | S | 3.03 | 35,300 | 106,959 | 336,138 | 371.4 K to 336.1 K (-9.50 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Buy | M | 0.74 | 150,000 | 111,000 | 371,438 | 221.4 K to 371.4 K (+67.74 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Option Exercise | M | 0.74 | 100,000 | 74,000 | 0 | |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 3.08 | 5,200 | 16,016 | 5,251 | 10.5 K to 5.3 K (-49.76 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 3.07 | 1,061 | 3,257 | 10,451 | 11.5 K to 10.5 K (-9.22 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.80 | 24,138 | 67,586 | 11,512 | 35.7 K to 11.5 K (-67.71 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 3.05 | 37,884 | 115,546 | 35,650 | 73.5 K to 35.7 K (-51.52 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.79 | 19,200 | 53,568 | 73,534 | 92.7 K to 73.5 K (-20.70 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.80 | 10,300 | 28,840 | 92,734 | 103 K to 92.7 K (-10.00 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.81 | 30,030 | 84,384 | 103,034 | 133.1 K to 103 K (-22.57 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.82 | 5,136 | 14,484 | 133,064 | 138.2 K to 133.1 K (-3.72 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.84 | 2,000 | 5,680 | 138,200 | 140.2 K to 138.2 K (-1.43 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.85 | 29,734 | 84,742 | 140,200 | 169.9 K to 140.2 K (-17.50 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.86 | 1,500 | 4,290 | 169,934 | 171.4 K to 169.9 K (-0.87 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.88 | 1,392 | 4,009 | 171,434 | 172.8 K to 171.4 K (-0.81 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Sell | S | 2.89 | 708 | 2,046 | 172,826 | 173.5 K to 172.8 K (-0.41 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Buy | M | 0.74 | 100,000 | 74,000 | 173,534 | 73.5 K to 173.5 K (+135.99 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Sell | S | 3.06 | 12,752 | 39,021 | 11,000 | 23.8 K to 11 K (-53.69 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Sell | S | 3.05 | 2,248 | 6,856 | 23,752 | 26 K to 23.8 K (-8.65 %) |
Jul 06 2009 | NVAX | NOVAVAX INC | Heaton Penny | VP & Chief Medical ... | Sell | S | 2.86 | 8,333 | 23,832 | 18,667 | 27 K to 18.7 K (-30.86 %) |
Jun 26 2009 | NVAX | NOVAVAX INC | Erck Stanley C | Director | Option Exercise | A | 2.44 | 20,000 | 48,800 | 20,000 | |
Jun 19 2009 | NVAX | NOVAVAX INC | Kopsidas Evdoxia E | Sr.Dir.Fin.,Prin.Ac ... | Option Exercise | A | 2.33 | 5,000 | 11,650 | 5,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | TANANBAUM JAMES B | Director | Option Exercise | A | 0.56 | 15,000 | 8,400 | 15,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 0.56 | 15,000 | 8,400 | 15,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Hage Raymond Joseph | Sr. VP. Commercial ... | Option Exercise | A | 0.56 | 60,000 | 33,600 | 60,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Option Exercise | A | 0.56 | 60,000 | 33,600 | 60,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Option Exercise | A | 0.56 | 175,000 | 98,000 | 175,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Option Exercise | A | 0.56 | 25,000 | 14,000 | 25,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Robinson Jim | VP, Technical & Qua ... | Option Exercise | A | 0.56 | 75,000 | 42,000 | 75,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | MARSH JOHN O JR | Director | Option Exercise | A | 0.56 | 15,000 | 8,400 | 15,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Option Exercise | A | 0.56 | 15,000 | 8,400 | 15,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | A | 0.56 | 15,000 | 8,400 | 15,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Heaton Penny | VP & Chief Medical ... | Option Exercise | A | 0.56 | 75,000 | 42,000 | 75,000 | |
Mar 09 2009 | NVAX | NOVAVAX INC | Kopsidas Evdoxia E | Dir.Fin.,Int.Princ. ... | Option Exercise | A | 0.56 | 7,500 | 4,200 | 7,500 | |
Sep 22 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.11 | 19,600 | 60,956 | 73,534 | 93.1 K to 73.5 K (-21.04 %) |
Sep 22 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.12 | 400 | 1,248 | 93,134 | 93.5 K to 93.1 K (-0.43 %) |
Sep 22 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 2.94 | 100 | 294 | 93,534 | 93.6 K to 93.5 K (-0.11 %) |
Sep 22 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 2.93 | 200 | 586 | 93,634 | 93.8 K to 93.6 K (-0.21 %) |
Sep 22 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 2.94 | 9,700 | 28,518 | 93,834 | 103.5 K to 93.8 K (-9.37 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Option Exercise | P | 3.62 | 175,902 | 636,765 | 175,902 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Option Exercise | P | 3.62 | 3,500 | 12,670 | 3,500 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Buy | P | 0.00 | 351,803 | 0 | 3,225,366 | 2.9 M to 3.2 M (+12.24 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Buy | P | 0.00 | 7,000 | 0 | 7,000 | 0 to 7 K |
Aug 04 2008 | NVAX | NOVAVAX INC | Robinson Jim | VP, Tech. & Quality ... | Option Exercise | P | 3.62 | 8,795 | 31,838 | 8,795 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Robinson Jim | VP, Tech. & Quality ... | Buy | P | 0.00 | 17,590 | 0 | 77,590 | 60 K to 77.6 K (+29.32 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | P | 3.62 | 8,795 | 31,838 | 8,795 | |
Aug 04 2008 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Buy | P | 0.00 | 17,590 | 0 | 77,590 | 60 K to 77.6 K (+29.32 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Option Exercise | P | 3.62 | 5,277 | 19,103 | 5,277 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Buy | P | 0.00 | 10,554 | 0 | 221,438 | 210.9 K to 221.4 K (+5.00 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | P | 3.62 | 33,878 | 122,638 | 33,878 | |
Aug 04 2008 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 0.00 | 67,756 | 0 | 911,056 | 843.3 K to 911.1 K (+8.03 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Heaton Penny | Chief Medical Offic ... | Option Exercise | P | 3.62 | 880 | 3,186 | 880 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Heaton Penny | Chief Medical Offic ... | Buy | P | 0.00 | 1,759 | 0 | 28,159 | 26.4 K to 28.2 K (+6.66 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Option Exercise | P | 3.62 | 500 | 1,810 | 500 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Johnston Thomas Scott | Vice President, Str ... | Buy | P | 0.00 | 1,000 | 0 | 26,000 | 25 K to 26 K (+4.00 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | Stigliano Len F | VP, CFO, Treasurer | Option Exercise | P | 3.62 | 5,277 | 19,103 | 5,277 | |
Aug 04 2008 | NVAX | NOVAVAX INC | Stigliano Len F | VP, CFO, Treasurer | Buy | P | 0.00 | 10,554 | 0 | 20,554 | 10 K to 20.6 K (+105.54 %) |
Aug 04 2008 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Option Exercise | P | 3.62 | 7,373 | 26,690 | 7,373 | |
Aug 04 2008 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Buy | P | 0.00 | 14,746 | 0 | 114,746 | 100 K to 114.7 K (+14.75 %) |
Aug 01 2008 | NVAX | NOVAVAX INC | TANANBAUM JAMES B | Director | Option Exercise | P | 3.62 | 17,591 | 63,679 | 17,591 | |
Aug 01 2008 | NVAX | NOVAVAX INC | TANANBAUM JAMES B | Director | Buy | P | 0.00 | 35,181 | 0 | 3,151,818 | 3.1 M to 3.2 M (+1.13 %) |
Mar 10 2008 | NVAX | NOVAVAX INC | TANANBAUM JAMES B | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | MARSH JOHN O JR | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Option Exercise | A | 2.61 | 25,000 | 65,250 | 25,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Singhvi Rahul | President and CEO | Option Exercise | A | 2.61 | 175,000 | 456,750 | 175,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 2.61 | 15,000 | 39,150 | 15,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Option Exercise | A | 2.61 | 60,000 | 156,600 | 60,000 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Stigliano Len F | VP, CFO and Treasur ... | Option Exercise | A | 2.61 | 32,500 | 84,825 | 32,500 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Robinson Jim | VP of Tech. & Qual. ... | Option Exercise | A | 2.61 | 37,500 | 97,875 | 37,500 | |
Mar 10 2008 | NVAX | NOVAVAX INC | Heaton Penny | Chief Medical Offic ... | Option Exercise | A | 2.61 | 75,000 | 195,750 | 75,000 | |
Feb 01 2008 | NVAX | NOVAVAX INC | Heaton Penny | Chief Medical Offic ... | Buy | P | 3.05 | 900 | 2,745 | 27,000 | 26.1 K to 27 K (+3.45 %) |
Feb 01 2008 | NVAX | NOVAVAX INC | Heaton Penny | Chief Medical Offic ... | Buy | P | 3.05 | 1,100 | 3,355 | 26,100 | 25 K to 26.1 K (+4.40 %) |
Jan 09 2008 | NVAX | NOVAVAX INC | Robinson Jim | VP,Technical & Qual ... | Buy | P | 3.07 | 5,000 | 15,325 | 60,000 | 55 K to 60 K (+9.09 %) |
Aug 29 2007 | NVAX | NOVAVAX INC | Singhvi Rahul | President, CEO | Buy | P | 3.04 | 1,100 | 3,342 | 210,884 | 209.8 K to 210.9 K (+0.52 %) |
Aug 29 2007 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.18 | 3,165 | 10,065 | 103,534 | 106.7 K to 103.5 K (-2.97 %) |
Aug 29 2007 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.17 | 700 | 2,219 | 106,699 | 107.4 K to 106.7 K (-0.65 %) |
Aug 29 2007 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.16 | 4,600 | 14,536 | 107,399 | 112 K to 107.4 K (-4.11 %) |
Aug 29 2007 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Sell | S | 3.15 | 2,035 | 6,410 | 111,999 | 114 K to 112 K (-1.78 %) |
Aug 27 2007 | NVAX | NOVAVAX INC | Stigliano Len F | VP, CFO, Treasurer | Buy | P | 3.14 | 10,000 | 31,400 | 10,000 | 0 to 10 K |
Aug 24 2007 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.02 | 10,000 | 30,200 | 843,300 | 833.3 K to 843.3 K (+1.20 %) |
Aug 23 2007 | NVAX | NOVAVAX INC | Robinson Jim | VP,Technical & Qual ... | Buy | P | 3.12 | 16,869 | 52,631 | 55,000 | 38.1 K to 55 K (+44.24 %) |
Aug 23 2007 | NVAX | NOVAVAX INC | Robinson Jim | VP,Technical & Qual ... | Buy | P | 3.11 | 3,131 | 9,737 | 38,131 | 35 K to 38.1 K (+8.95 %) |
Aug 23 2007 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.10 | 20,000 | 61,980 | 833,300 | 813.3 K to 833.3 K (+2.46 %) |
Jul 03 2007 | NVAX | NOVAVAX INC | Stigliano Len F | VP, CFO and Treasur ... | Option Exercise | A | 2.98 | 225,000 | 670,500 | 225,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | TANANBAUM JAMES B | Director | Option Exercise | A | 2.77 | 15,000 | 41,550 | 15,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | Hage Raymond Joseph | SVP, Commercial Ope ... | Option Exercise | A | 2.77 | 75,000 | 207,750 | 75,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | CHURCH JEFFREY WAYNE | VP, CFO, Treasurer ... | Option Exercise | A | 2.77 | 25,000 | 69,250 | 25,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Option Exercise | A | 2.77 | 250,000 | 692,500 | 250,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | LAMBERT JOHN A | Director | Grant | A | 0.00 | 100,000 | 0 | 100,000 | 0 to 100 K |
Mar 09 2007 | NVAX | NOVAVAX INC | MCMANUS MICHAEL A JR | Director | Option Exercise | A | 2.77 | 15,000 | 41,550 | 15,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | ODONNELL DENIS M | Director | Option Exercise | A | 2.77 | 15,000 | 41,550 | 15,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | MARSH JOHN O JR | Director | Option Exercise | A | 2.77 | 15,000 | 41,550 | 15,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | Monath Thomas P | Director | Option Exercise | A | 2.77 | 15,000 | 41,550 | 15,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Option Exercise | A | 2.77 | 100,000 | 277,000 | 100,000 | |
Mar 09 2007 | NVAX | NOVAVAX INC | Singhvi Rahul | President & CEO | Option Exercise | A | 2.77 | 100,000 | 277,000 | 100,000 | |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Option Exercise | M | 3.98 | 7,500 | 29,850 | 7,500 | |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Option Exercise | M | 1.48 | 3,750 | 5,550 | 11,250 | |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Option Exercise | M | 1.34 | 9,000 | 12,060 | 6,000 | |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Sell | D | 4.41 | 7,500 | 33,075 | 13,514 | 21 K to 13.5 K (-35.69 %) |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Grant | A | 3.98 | 7,500 | 29,850 | 21,014 | 13.5 K to 21 K (+55.50 %) |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Sell | D | 4.09 | 3,750 | 15,327 | 13,514 | 17.3 K to 13.5 K (-21.72 %) |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Grant | A | 1.48 | 3,750 | 5,550 | 17,264 | 13.5 K to 17.3 K (+27.75 %) |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Sell | D | 4.09 | 9,000 | 36,784 | 13,514 | 22.5 K to 13.5 K (-39.98 %) |
Nov 01 2006 | NVAX | NOVAVAX INC | Hall Patricia | Chief Accounting Of ... | Grant | A | 1.34 | 9,000 | 12,060 | 22,514 | 13.5 K to 22.5 K (+66.60 %) |
Aug 23 2006 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.51 | 400 | 1,404 | 4,000 | 3.6 K to 4 K (+11.11 %) |
Aug 23 2006 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.49 | 3,600 | 12,564 | 3,600 | 0 to 3.6 K |
Aug 23 2006 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.55 | 4,000 | 14,200 | 4,000 | 0 to 4 K |
Aug 23 2006 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 3.55 | 50,000 | 177,500 | 813,300 | 763.3 K to 813.3 K (+6.55 %) |
Apr 11 2006 | NVAX | NOVAVAX INC | EVANS GARY C | Director | Buy | P | 4.95 | 25,000 | 123,750 | 763,300 | 738.3 K to 763.3 K (+3.39 %) |
Mar 10 2006 | NVAX | NOVAVAX INC | ODONNELL DENIS M | Director | Sell | S | 5.42 | 74,155 | 401,920 | 221,495 | 295.7 K to 221.5 K (-25.08 %) |
Mar 10 2006 | NVAX | NOVAVAX INC | ODONNELL DENIS M | Director | Sell | S | 5.38 | 157,400 | 846,812 | 221,495 | 378.9 K to 221.5 K (-41.54 %) |
Mar 06 2006 | NVAX | NOVAVAX INC | KELLY MITCHELL J | Director | Sell | S | 5.38 | 800,000 | 4,306,960 | 500 | 800.5 K to 500 (-99.94 %) |
Mar 06 2006 | NVAX | NOVAVAX INC | KELLY MITCHELL J | Director | Sell | S | 5.41 | 939,601 | 5,087,000 | 500 | 940.1 K to 500 (-99.95 %) |